CVS Health Corp vs Zoom Video Communications, Inc. — how do they compare? CVS Health Corp trades at $85.46 (market cap $112.29B), while Zoom Video Communications, Inc. trades at $95.24 (market cap $27.62B). The key difference: CVS Health Corp is far larger — about 4.1× Zoom Video Communications, Inc.'s market cap, and CVS Health Corp pays a 3.03% dividend while Zoom Video Communications, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Zoom Video Communications, Inc. for 92 Days on average.
| CVS | ZM | |
|---|---|---|
Market Cap | $112.29B | $27.62B |
Volume | 7,763,676 | 3,913,188 |
Sector | Health | Technology |
52-Week High | $110.60 | $111.88 |
52-Week Low | $70.08 | $72.72 |
Typical Hold Time | 83 Days | 92 Days |
Enterprise Value | $174.64B | $20.43B |
Dividend Yield | 3.03% | — |
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.95, up 1.76% with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 26% upside. Recent quarterly earnings consistently beat expectations, with Q2 2026 EPS of $2.58 surpassing the $1.85 estimate. Revenue growth remains solid at $402.07 billion for 2025, though net margins compressed to 1.18%. Technical indicators show a bullish overall signal with support at $87 and resistance at $89.
The outlook remains positive given CVS's dominant market position and Medicare expansion plans, but investors face risks from reimbursement pressures and ongoing legal investigations. Earnings growth and successful execution of healthcare services integration represent the primary catalysts for continued stock appreciation.
Zoom Communications (ZM) trades at $94.77, up 0.61% today, with a bullish technical signal supported by moving averages. The company reported strong profitability with a net income margin of 65.19% and ROE of 32.14% for 2026. Recent earnings beats in Q1 and Q2 2026, alongside AI-driven product launches like the Revenue OS, highlight growth momentum. Analyst consensus is a Buy with a $118.08 price target, though mixed sentiment persists with 55.1% Hold ratings.
The outlook for ZM is positive, driven by AI integration and earnings strength, but risks include reliance on international sales and competitive pressures. Upside potential exists if the company meets Q3 2026 EPS expectations of $1.50, though volatility near resistance at $95-$97 may challenge short-term gains.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →Zoom Video Communications, Inc. develops a people-centric cloud service that transforms real-time collaboration experience. The Company offers unified meeting experience, a cloud service that provides a 3-in-1 meeting platform with HD video conferencing, mobility, and web meetings. Zoom Video Communications serves customers worldwide.
Read more on ZM →